Literature DB >> 31763426

Penile granulomatosis with polyangiitis.

Séverine Amico1, Guillaume Ballan2, Sophie Charles1, Stéphane Marce3, Suzanne Devaux1.   

Abstract

Entities:  

Keywords:  ANCA, anti-neutrophil cytoplasmic antibodies; GPA, granulomatosis with polyangiitis; granuloma; granulomatosis with polyangiitis; myasthenia gravis; penis

Year:  2019        PMID: 31763426      PMCID: PMC6864285          DOI: 10.1016/j.jdcr.2019.09.001

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.

Introduction

Granulomatosis with polyangiitis (GPA) is a systemic form of vasculitis that predominantly affects small and medium-sized vessels. The organs often involved are the kidneys and respiratory tract. Diagnosis can be established based on the histologic findings of necrotizing granulomatous inflammation and vasculitis and positive test results for anti-neutrophil cytoplasmic antibodies (ANCAs). Male urogenital manifestations are found in fewer than 1% of cases in large cohorts, and often the upper respiratory tract (90%-100%), lungs (81%-87%), and kidneys (45%-60%) are also involved. Myasthenia gravis is a condition characterized by weakness and fatigue of various muscles in the body. It is caused by autoantibodies directed against certain components of the muscle membrane at the neuromuscular junction. Diagnosis is made via the detection of acetylcholine receptor antibodies or antibodies against muscle-specific tyrosine kinase (MuSK). We present a case of penile ulceration and induration as the main manifestation of GPA in a patient for whom ocular myasthenia gravis was diagnosed simultaneously.

Case report

The patient is a 70-year-old man who presented with a painful penile ulcer and induration for 3 months. His medical history showed type 2 diabetes mellitus, hepatic steatosis, and dyslipidemia. He was first treated unsuccessfully with ceftriaxone and pristinamycin. Three months later, with the presumptive diagnosis of a neoplastic tumor, surgical treatment with posthectomy was carried out. Postsurgical examination showed a 6-cm induration of the penis and pubis area, with a reduction in the size of the penis, and a painful glans ulceration (Fig 1). He also complained of polyarthralgia, and on physical examination arthritis of the right knee was found.
Fig 1

Clinical photograph before treatment: glans ulceration and penile induration

Clinical photograph before treatment: glans ulceration and penile induration Histopathologic analysis of posthectomy showed necrotizing epithelioid granuloma and chronic vascular lesions (Fig 2). Results of biological investigations for sexually transmitted infections, tuberculosis, and sarcoidosis were negative. Immunologic assessment found positive cytoplasmic ANCAs at a titer of 1/160, with a cytoplasmic pattern and anti-PR3 antibodies at 468 IU, suggesting the diagnosis of urogenital and rheumatologic granulomatosis with polyangiitis. Full-body computed tomography results were normal and ruled out any pulmonary or sinus involvement of GPA. Renal function was normal, and proteinuria results were negative.
Fig 2

Histology: Necrotizing epithelioid granuloma and vascular infiltration. Hematoxylin, Eosin and Safran (HES) staining, Magnification ×200.

Histology: Necrotizing epithelioid granuloma and vascular infiltration. Hematoxylin, Eosin and Safran (HES) staining, Magnification ×200. Furthermore, complete physical examination also showed intermittent binocular diplopia, which worsened at the end of the day, and left eyelid ptosis. Ophthalmic examination could not identify the type of diplopia. Cerebral magnetic resonance imaging was not contributive. Testing for acetylcholine receptor antibodies was performed and showed positivity, with a value of more than 13 nmol/mL (standard value, <0.2 nmol/L). The patient was treated with prednisone 1 mg/kg per day by mouth and trimethoprim-sulfamethoxazole to prevent relapses of this localized form of GPA. The treatment proved to be effective after 1 month: the pubis induration decreased to 1 cm in size, and the ulceration of the penis healed (Fig 3). Plasmatic levels of ANCAs were still at 1/160 after 6 months, but ant-PR3 decreased to 74 IU, and prednisone was gradually decreased (removing 10 mg every 15 days for 2 months and then 5 mg every month). For his myasthenia gravis condition, treatment with pyridostigmine induced quick and total recovery.
Fig 3

Clinical photograph one month after treatment (corticosteroids and trimethoprim-sulfamethoxazole): healing of the ulceration is evident.

Clinical photograph one month after treatment (corticosteroids and trimethoprim-sulfamethoxazole): healing of the ulceration is evident.

Discussion

Usually, GPA affects lungs, kidney, and sinuses. Genitourinary involvement is rare and occurs in fewer than 1% of cases, of which 20 cases with penile involvement were described in the literature. Moreover, our patient exhibited an isolated manifestation, which is uncommon, and it was associated with myasthenia. To our knowledge, this association has not been described to date. We studied 32 case reports of male urogenital manifestations of GPA. In 15 cases, GPA diagnosis included manifestations of the sinuses, lungs, and/or kidneys that precede or occur at the same time as the urologic symptoms.2, 3, 4, 5 Because of these severe manifestations, patients are generally treated with corticosteroids and immunosuppressive therapies (mostly cyclophosphamide), with expected adverse effects. Urogenital symptoms were the first evidence of GPA in 8 of the 32 case reports, followed months later by more severe organ involvement.2, 3, 4, 5, 6 Diagnosis was made secondarily with the appearance of classical localizations of vasculitis, which led to the use of corticosteroids and immunosuppressive therapy. The 9 cases of isolated urogenital involvement were treated differently.1, 4, 5, 7, 8, 9, 10 In particular, 2 cases of orchitis were treated only surgically,7, 9 leading to good response and diminution of the ANCA titer. Other cases were managed medically with corticosteroids, cyclophosphamide, azathioprine, and/or methotrexate, depending on the severity and the treatment response of the area involved. In our case, considering the absence of any kidney, lung, or sinus involvement of GPA, we decided to treat the patient with corticosteroids 1 mg/kg per day with gradual decrease in dosage. Trimethoprim-sulfamethoxazole was added as an adjunct treatment and has been proven to reduce relapses of the disease. After 6 months of follow-up, no disease relapse was noted, and symptoms were controlled with trimethoprim-sulfamethoxazole and oral prednisone at a dose of 0.3 mg/kg/d. To our knowledge, the association of GPA with myasthenia has never been described. The occurrence of 2 autoimmune diseases suggested the possibility of neoplasia. However, investigations (full-body computed tomography, prostate-specific antigen, blood count, protein electrophoresis) ruled out any signs of neoplasia, particularly thymoma. Isolated urogenital manifestations of GPA may represent a difficult diagnostic challenge because it can simulate neoplasia or infection and has nonspecific histologic findings. However, early diagnosis can result in quicker introduction of immunosuppressive therapy, leading to a better response and, potentially avoiding surgical treatment. This diagnosis should be evoked in patients presenting with unexplained chronic urogenital manifestations with histologic granuloma.
  11 in total

1.  Glans penis ulceration revealing Wegener's granulomatosis.

Authors:  N Bories; C Becuwe; M C Marcilly; F Wolf; B Balme; L Thomas
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

Review 2.  [Wegener's granulomatosis with urethral-penile location. Apropos of a case].

Authors:  B Doré; P Duriez; P Grange; J Aubert
Journal:  Ann Urol (Paris)       Date:  1990

3.  Wegener granulomatosis. Unusual cause of necrotizing urethritis.

Authors:  M Fowler; S A Martin; W T Bowles; R Packman; A L Katzenstein
Journal:  Urology       Date:  1979-07       Impact factor: 2.649

Review 4.  Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature.

Authors:  Jean-François Dufour; Thomas Le Gallou; Jean-François Cordier; Olivier Aumaître; Laurent Pinède; Elisabeth Aslangul; Christian Pagnoux; Isabelle Marie; Xavier Puéchal; Olivier Decaux; Alain Dubois; Christian Agard; Alfred Mahr; François Comoz; Jonathan Boutemy; Christiane Broussolle; Loïc Guillevin; Pascal Sève; Boris Bienvenu
Journal:  Medicine (Baltimore)       Date:  2012-03       Impact factor: 1.889

5.  Wegener's granulomatosis involving the urogenital tract.

Authors:  A Davenport; S E Downey; S Goel; A G Maciver
Journal:  Br J Urol       Date:  1996-09

6.  Limited Wegener's granulomatosis of the epididymis and testis.

Authors:  Shang-Sen Lee; Shou-Hung Tang; Guang-Huan Sun; Cheng-Ping Yu; Jong-Shiaw Jin; Sun-Yran Chang
Journal:  Asian J Androl       Date:  2006-07-11       Impact factor: 3.285

Review 7.  Urologic and male genital manifestations of granulomatosis with polyangiitis.

Authors:  Marco A Alba; Jorge Moreno-Palacios; Sara Beça; María C Cid
Journal:  Autoimmun Rev       Date:  2015-05-28       Impact factor: 9.754

8.  Wegener's granulomatosis of the penis: diagnosis and management.

Authors:  Robert Adam; Sydney Katz; Ken Lee; Michael Jewett; Ronald Kodama
Journal:  Can J Urol       Date:  2004-08       Impact factor: 1.344

9.  Granulomatous vasculitis of the penis with glomerulonephritis.

Authors:  E J Vella; D G Waller
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

10.  Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

Authors:  C A Stegeman; J W Tervaert; P E de Jong; C G Kallenberg
Journal:  N Engl J Med       Date:  1996-07-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.